Profile data is unavailable for this security.
About the company
Cathay Biotech Inc is a China-based company principally engaged in the research, development, production and sales of new bio-based materials. The Company’s main products include a series of biological long-chain dibasic acids (DC10-DC18), bio-based pentamethylenediamine, and a series of bio-based polyamides. The Company's products are mainly used in textiles, engineering materials, transportation logistics, building materials, new energy, medicine, electronic appliances, daily consumer goods and other fields. The Company's brands include TERRYL, a bio-based polyamide fiber brand for the textile sector, and ECOPENT, a brand for engineering materials. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)3.29bn
- Net income in CNY594.46m
- Incorporated2000
- Employees1.74k
- LocationCathay Biotech Inc4th Floor, Building 51690 Cailun Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201114ChinaCHN
- Phone+86 2 150801916
- Fax+86 2 150801386
- Websitehttps://www.cathaybiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cathay Biotech Inc | 3.29bn | 594.46m | 39.24bn | 1.74k | 59.17 | 2.23 | -- | 11.93 | 0.9194 | 0.9194 | 5.07 | 24.40 | 0.1574 | 1.74 | 10.28 | 1,895,025.00 | 2.68 | 3.34 | 3.66 | 4.75 | 32.25 | 33.63 | 17.00 | 22.74 | 6.16 | -- | 0.013 | 41.59 | 39.91 | 9.07 | 33.41 | 0.4175 | 10.53 | -- |
| Zhejiang Sanmei Chemical Industry Co Ltd | 5.43bn | 1.81bn | 41.42bn | 2.04k | 22.94 | 5.44 | -- | 7.63 | 2.96 | 2.96 | 8.90 | 12.47 | 0.664 | 5.38 | 10.80 | 2,666,586.00 | 21.96 | 7.45 | 24.96 | 8.29 | 46.93 | 19.52 | 33.08 | 12.15 | 4.33 | -- | 0.0621 | 31.73 | 21.17 | 0.5278 | 178.40 | 3.81 | 36.66 | 6.96 |
| Hubei Xingfa Chemicals Group Co Ltd | 30.13bn | 1.61bn | 41.60bn | 14.12k | 26.46 | 1.88 | -- | 1.38 | 1.41 | 1.41 | 26.52 | 19.83 | 0.6095 | 7.17 | 12.11 | 2,133,502.00 | 3.56 | 7.92 | 5.33 | 12.50 | 16.83 | 23.17 | 5.84 | 11.73 | 0.3912 | 15.81 | 0.4016 | 27.06 | 0.4074 | 9.50 | 14.33 | 44.08 | 6.73 | 58.49 |
| XTC New Energy Materials Xiamen Co Ltd | 16.47bn | 678.79m | 41.73bn | 3.34k | 60.93 | 4.63 | -- | 2.53 | 1.36 | 1.36 | 32.93 | 17.85 | 1.03 | 4.22 | 5.37 | 4,926,332.00 | 4.24 | 5.36 | 7.17 | 9.12 | 9.59 | 8.26 | 4.12 | 3.59 | 0.8858 | 21.86 | 0.0634 | 24.83 | -23.19 | 13.76 | -6.33 | 26.91 | 10.52 | -- |
| Skshu Paint Co Ltd | 12.35bn | 665.21m | 41.91bn | 9.00k | 63.00 | 12.90 | -- | 3.39 | 0.9016 | 0.9016 | 16.74 | 4.40 | 0.8358 | 11.15 | 2.99 | 1,372,943.00 | 4.32 | 1.59 | 13.41 | 4.97 | 31.91 | 29.71 | 5.17 | 1.69 | 0.6845 | 6.99 | 0.5287 | 44.16 | -2.97 | 15.18 | 91.27 | -3.95 | 9.20 | -- |
| Sichuan Hongda Co Ltd | 3.81bn | -31.88m | 43.14bn | 2.55k | -- | 13.56 | -- | 11.32 | -0.0189 | -0.0189 | 1.75 | 1.20 | 1.30 | 7.87 | 107.55 | 1,494,197.00 | -1.09 | -15.47 | -1.77 | -73.61 | 3.81 | 8.82 | -0.8364 | -13.32 | 3.96 | -1.19 | 0.00 | -- | 12.68 | 6.02 | 137.68 | -15.64 | -6.96 | -- |
Data as of Feb 06 2026. Currency figures normalised to Cathay Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
15.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HBM Partners AG (Investment Management)as of 01 Apr 2025 | 35.62m | 6.11% |
| China Asset Management Co., Ltd.as of 30 Sep 2024 | 22.54m | 3.86% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 15.36m | 2.63% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 5.75m | 0.99% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 2.84m | 0.49% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 1.81m | 0.31% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.47m | 0.25% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 1.15m | 0.20% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 791.78k | 0.14% |
| CPIC Fund Management Co. Ltd.as of 30 Jun 2025 | 763.13k | 0.13% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
